Elizabeth Charytonowicz
- Oncology top 5%
- Cancer-related Molecular Pathways 4
- Cancer Cells and Metastasis 3
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 2
-
- Sarcoma Diagnosis and Treatment 3
- Biotechnology top 5%
- Cancer Research and Treatments 3
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 3
-
- Bladder and Urothelial Cancer Treatments 8
-
- Radiomics and Machine Learning in Medical Imaging 2
- Co-authors
- Carlos Cordon‐CardoIgor MatushanskyNicholas D. SocciZuo‐Feng ZhangMarta Sänchez‐CarbayoJoslyn MillsGeoffrey ChildsMichael B. Prystowsky
- Journals
- Clinical & Translational Oncology (2 papers)American Journal Of Pathology (2 papers)Nature Medicine (1 paper)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Elizabeth Charytonowicz
23 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Oncology 844
- Cancer Research 321
- Pulmonary and Respiratory Medicine 668
- Biotechnology 134
- Molecular Biology 1.0k
Countries citing papers authored by Elizabeth Charytonowicz
This map shows the geographic impact of Elizabeth Charytonowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Charytonowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Charytonowicz more than expected).
Fields of papers citing papers by Elizabeth Charytonowicz
This network shows the impact of papers produced by Elizabeth Charytonowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Charytonowicz. The network helps show where Elizabeth Charytonowicz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth Charytonowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2018 | 17 | |
| 3 | 2017 | 10 | |
| 4 | 2012 | 338 | |
| 5 | 2012 | 14 | |
| 6 | 2011 | 11 | |
| 7 | 2009 | 19 | |
| 8 | 2009 | 109 | |
| 9 | 2008 | 109 | |
| 10 | 2007 | 218 | |
| 11 | 2007 | 32 | |
| 12 | 2003 | 45 | |
| 13 | 2003 | 146 | |
| 14 | 2002 | 212 | |
| 15 | Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. | 2002 | 156 |
| 16 | Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network. | 1998 | 20 |
| 17 | Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors. | 1997 | 180 |
| 18 | 1995 | 13 | |
| 19 | Blood group antigen expression in bladder tumors: An immunohistochemical study of superficial bladder lesions | 1994 | 5 |
| 20 | 1994 | 119 |
About Elizabeth Charytonowicz
Elizabeth Charytonowicz is a scholar working on Oncology, Biotechnology and Surgery, having authored 23 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer-related Molecular Pathways (4 papers), Cancer Research and Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer Cells and Metastasis (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Oncology (844 citations), Cancer Research (321 citations) and Pulmonary and Respiratory Medicine (668 citations). Elizabeth Charytonowicz has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Carlos Cordon‐Cardo, Igor Matushansky, Nicholas D. Socci, Zuo‐Feng Zhang, Marta Sänchez‐Carbayo, Joslyn Mills, Geoffrey Childs, Michael B. Prystowsky, Ming-Lan Lu and Guido Dalbagni. Their work appears in journals such as Clinical & Translational Oncology, American Journal Of Pathology, Nature Medicine, British Journal of Cancer and Human Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.